Imaging biomarkers for the treatment of esophageal cancer

Esophageal cancer is known as one of the malignant cancers with poor prognosis. To improve the outcome, combined multimodality treatment is attempted. On the other hand, advances in genomics and other “omic” technologies are paving way to the patient-oriented treatment called “personalized” or “prec...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayano, Koichi, Ohira, Gaku, Hirata, Atsushi, Aoyagi, Tomoyoshi, Imanishi, Shunsuke, Tochigi, Toru, Hanaoka, Toshiharu, Shuto, Kiyohiko, Matsubara, Hisahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603816/
https://www.ncbi.nlm.nih.gov/pubmed/31293338
http://dx.doi.org/10.3748/wjg.v25.i24.3021
Descripción
Sumario:Esophageal cancer is known as one of the malignant cancers with poor prognosis. To improve the outcome, combined multimodality treatment is attempted. On the other hand, advances in genomics and other “omic” technologies are paving way to the patient-oriented treatment called “personalized” or “precision” medicine. Recent advancements of imaging techniques such as functional imaging make it possible to use imaging features as biomarker for diagnosis, treatment response, and prognosis in cancer treatment. In this review, we will discuss how we can use imaging derived tumor features as biomarker for the treatment of esophageal cancer.

Ejemplares similares